A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

Organon

Status and phase: Completed; Phase 3

Conditions: Asthma, Bronchial

Treatments: Drug: Comparator : fluticasone propionate / Duration of Treatment: 1 Year; Drug: MK0476, montelukast sodium / Duration of Treatment: 1 Year

Study type: Interventional

Funder types: Industry

Identifiers

NCT00489346

2007_574

0476-910

Details and patient eligibility

About

A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.

Enrollment: 994 patients

Sex: All

Ages: 6 to 14 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient is male or female, 6-14 years of age with mild persistent asthma
• Patient has a history of the following symptoms: wheezing, chest tightness, cough, etc.
• Patient has asthma diagnosed by a doctor

Exclusion criteria

• Patient is hospitalized
• Patient has had major surgery or participated in another clinical trial in the last 4 weeks
• Patient has been on a breathing tube for asthma

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind